Medtronic posts 24-month TITAN 2 data showing sustained nocturia reduction with Altaviva device

Bitget2026/10/06 21:01

Medtronic disclosed new 24-month exploratory results from the TITAN 2 pivotal trial at the 47th AUGS Annual Scientific Meeting. The analysis showed durable reductions in nightly urination episodes, with sleep-related quality of life improving for many patients. The update supports the clinical profile of Altaviva, an implantable tibial neuromodulation device cleared in September 2025 for urge urinary incontinence. Medtronic also launched the ENDURANCE post-approval study, a five-year, real-world trial tracking 170 implanted patients across up to 30 US centers. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Goldman Sachs trading desk "inundated with calls but buyers are nowhere to be found": AI trading cools off due to midterm election results, Nasdaq loses over 2 trillions USD in a single day

Goldman Sachs' equity trading desk has been flooded with inquiries from investors—all asking the same question: how deep will the tech stock sell-off go? However, real buyers willing to step in are proving hard to find.

智通财经•2026/11/05 22:47

Updated: Boosted by rising crude oil prices, U.S. shale oil producer EOG Resources reports profits exceeding expectations

路透社•2026/11/05 22:46

BUZZ-Tandem Diabetes Care appoints Janet Banks as CEO, shares rise

路透社•2026/11/05 22:41

South Korea denies considering large-scale purchases of long-term U.S. Treasury bonds, stating that Korean media reports are inconsistent with the facts.

The Ministry of Economy and Finance of South Korea and the Bank of Korea (BOK) issued a joint statement refuting a local media report. The report had claimed that, in response to significant foreign capital outflows, Seoul was considering purchasing a large amount of U.S. government bonds. Both institutions emphasized that the composition and specific details regarding the management of South Korea's foreign exchange reserve assets are not disclosed to the public.

华尔街见闻•2026/11/05 22:36